The current issue
- Drug-induced nephrotoxicity – part II
Miłosz Miedziaszczyk, Patrycja Ciabach, Aneta Szudy, Żaneta Dąbrowska, Ilona Idasiak-Piechocka, Edyta Szałek
- JAK inhibitors – new drugs for the treatment of rheumatoid arthritis
Adrianna Dadej, Daniela Dadej, Szymon Tomczak, Anna Jelińska
- Olaparib – new opportunities in oncological therapy
Marta Grzebalska, Joanna Stanisławiak-Rudowicz, Edyta Szałek
- Adverse effects following immunisation diagnosis and reporting in terms of vaccination against COVID-19
Beata Zastawna, Roman Załuska, Joanna Olszewska, Marcin Grabowski
- Antisense oligonucleotides – structure, mechanisms of action and therapeutic application
Dawid Dorna, Jarosław Paluszczak
- The effects of phytoestrogens in hormone-dependent cancers
Joanna Bartkowiak-Wieczorek
- History and chemistry of curcumin
Joanna Kuźmińska, Agnieszka Sobczak, Marcin Wierzchowski, Tomasz Gośliński, Anna Jelińska
- Metamizole-induced hypersensitivity – a case report and literature review
Katarzyna Korzeniowska, Artur Cieślewicz, Anna Jabłecka, Michał Szymański
- Omeprazole-induced gynecomastia – a case report and literature review
Katarzyna Korzeniowska, Katarzyna Malesza
- Flagellate erythema, adverse drug reaction during Bleomycin therapy
Aneta Szudy, Daria Górecka, Agnieszka Karbownik, Joanna Stanisławiak-Rudowicz
